EBMT Archives - MaaT Pharma

Press Releases

April 22, 2024: MaaT Pharma to Hold Annual General Meeting on May 28, 2024

MaaT Pharma to Hold Annual General Meeting on May 28, 2024 Lyon, France, April 22nd…

MaaT PharmaApril 22, 2024

Press Releases

April 15, 2024: MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event

MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in…

MaaT PharmaApril 15, 2024

Press Releases

March 12, 2024: MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference

MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be…

MaaT PharmaMarch 12, 2024

© 2026 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club